Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-09-11 00:00:00 ET · period of report 2025-09-10 · accession 0001106578-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-09-11 | 2025-09-10+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $397.98 | -8,000 | 130 | -98% | -$3.18M |
| DMT | 2025-09-11 | 2025-09-10+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +8,000 | 4,130 | New | +$962.1K |
| DMT | 2025-09-11 | 2025-09-10+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $0.00 | -8,000 | 282.0K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-11 | S | D | 4,000 | $397.23 | 130 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $396.97 to $397.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2025-09-11 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 3 | Common | Common Stock | 2025-09-10 | S | D | 2,000 | $398.11 | 2,130 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $397.72 to $398.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2025-09-10 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 5 | Common | Common Stock | 2025-09-10 | S | D | 2,000 | $399.33 | 130 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $399.09 to $399.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Derivative | Stock Option | 2025-09-11 | M | D | 4,000 | $0.00 | 278,000 | D | $120.26 · 2016-03-15 to 2026-03-15 | 4,000 Common Stock | |
| 7 | Derivative | Stock Option | 2025-09-10 | M | D | 4,000 | $0.00 | 282,000 | D | $120.26 · 2016-03-15 to 2026-03-15 | 4,000 Common Stock |